Aldama, De Larrea and Dallas: A Spanish Empire Built on an Unhealed Knee

Santi Aldama left last season after his 43rd game. Not a suspension, not a broken contract negotiation, not a rotation decision. A knee. A knee arthroscopy closed the campaign of the 25-year-old, whom the Dallas Mavericks brought in to fill the gap of a big man who can stretch the floor and move the ball. Before the injury appeared, he averaged 14.0 points per game — a number I will return to later, because it cannot stand on its own.

This is the story of a team building a Spanish talent pipeline, of a 20-year-old rookie just out of Valencia in the EuroLeague, and of a veteran trying to prove his knee still has enough for a full NBA season. Three character threads, one question: what is Dallas actually buying?

Context: the Spanish pipeline and a rookie with no data

Sergio de Larrea is 20, leaving Valencia of the EuroLeague for the NBA. There is not a single minute of play on American soil to reference. He belongs to the tall guard archetype — as described in his own introductory press conference — a player who prioritizes passing over scoring, with play vision rated as excellent. He is labeled a combo guard, meaning he can play both with and without the ball, both as a lead initiator and as an off-ball option.

Aldama has spoken about his countryman in the language of an older brother: "I just try to help him in everything I can." The two have known each other for a long time, sharing the Spanish national team system. From a certain angle, Dallas is not buying two separate players. They are buying a cultural cluster — and this is a strategy proven across many modern NBA teams, where European rookies adapt faster with a compatriot beside them.

The broader context is also notable. The preseason series in Macao against Houston is a clear commercial signal: the NBA continues to invest in the Chinese market, and these games double as a stage for newly acquired international players. Dallas opens the season on the road at Houston per the published schedule. I remember writing about Hachimura when he was still playing in Japan's U18 league, when no sports outlet bothered to build a stat sheet for him. I found gold in Japanese youth basketball, where everyone else saw only snow. The principle I drew from it is simple: never judge a European import solely by his own story. Find the data. With De Larrea, the data is entirely blank. That is not his flaw. It is our flaw — those of us trying to analyze him.

Core analysis: pipeline, role, and an unverified number

At the purely tactical layer, Dallas's problem has two variables. The first is Aldama: a big man over 2.08m who can shoot from distance and pass the ball, the "pick-and-pop / secondary creator" archetype that the modern NBA values. His value lies in drawing an opposing defender out of the paint, while still reading the game well enough to create for teammates. The second variable is De Larrea: a tall guard who prioritizes playmaking, who in theory benefits from the very spacing Aldama creates.

Aldama makes a notable argument — that the NBA's bigger court and higher-level offensive threats will amplify De Larrea's passing. Mechanically, this is a sound axiom. A bigger court creates more space. Opposing defenses must spread wider. A guard with good vision finds more passing lanes. This is the FIBA-to-NBA transition logic any analyst can confirm. But it remains a theoretical argument, not a demonstrated result. And the one making it is De Larrea's teammate, not an independent analyst.

There is one genuinely tactical point here, and it lies elsewhere. A tall pass-first guard typically gains value in the playoffs, because height at the point of attack resists switching defenses and physical pressure, and passing vision retains value when help defense loads up. A 1.95m guard can see over a defense in a way a 1.83m guard cannot. This is why the archetype is becoming a league-wide trend. But we are talking about a 20-year-old with zero NBA minutes. That is not a verified trait. It is a projection, and every projection about a rookie must carry a wide variance band.

With Aldama, the story is in a completely different place. Across five seasons in Memphis, he played 288 games — about 58 per season. Last season, that number dropped to 43, and ended with arthroscopy. The defining feature of Aldama's career, plainly stated, is not scoring. It is availability. A player averaging 58 games season after season is a stable-value asset; a player who plays 43 then walks into surgery is an asset with a question mark. And last season, that question mark was the only answer.

This is where I must address the 14.0 points figure. It appears in the data I collected, but comes with no efficiency context — no true shooting percentage, no effective field goal percentage, no usage rate, no minutes. A 43-game season cut short by surgery is not a reliable baseline. The 14.0 could be a small-sample anomaly, a role-shift result, or a consequence of being given more ball on a short-handed roster. I have no basis to dismiss it, and no basis to build any expectation on it. It sits in a state of pending verification.

So what is Dallas buying? At the operational layer, the most reasonable answer is: a pipeline. A Spanish big man in career transition, a 20-year-old Spanish guard on a cheap rookie contract, sharing a national-team system. This is roster-building around a cultural cluster — which modern NBA teams have learned can reduce adaptation friction for European rookies. It is cheap. It is flexible. It gives Dallas rookie-surplus value if De Larrea hits. And it does not require Dallas to go all-in on a superstar. It is a rational strategy, on paper. But it places two cards side by side without separating their risk.

Contrarian angle: the "Spanish brotherhood" story is hiding the real risk

The media is selling this as a sentimental story: two Spaniards, one older brother, one younger, conquering the NBA together. It is charming. It sells jerseys. It generates pretty headlines in the early-season media window. And it has almost no predictive value.

Data does not lie, but the people reading it do. The story of Aldama mentoring De Larrea is built on self-reported, uniformly positive quotes: "It's something special," "very exciting," "he is a professional." These statements are not factually wrong. They simply measure nothing. A newly arrived player always says good things about his new team — it is part of the job, part of building a relationship with the organization and the fanbase. Reading them as a performance forecast is a basic analytical error.

Dallas's real risk is not whether De Larrea adapts. A 20-year-old rookie from the EuroLeague will almost certainly need time — that is the rule, not the exception. The real risk is Aldama's knee. He has undergone joint surgery. He missed the FIBA World Cup qualifying window due to recovery. He is participating in the early phase of training camp under medical-staff management, with a participation level that "could vary." No medical clearance date has been announced to the public.

A player who has already undergone one knee procedure and missed a competitive summer carries an above-average re-injury probability. This is a real, evidenced, quantifiable risk. It is not a hypothesis. It is on the table. The way the medical staff manages the recovery — rather than offering a clear timeline — suggests Dallas is preserving flexibility for itself, both on health and on NBA load-management compliance.

And here is the most interesting thing about Dallas's structure: their two risk profiles are linked. If Aldama is not available, De Larrea loses his closest adaptation guide. If De Larrea needs time to integrate — and a 20-year-old rookie from the EuroLeague almost certainly does — the burden falls on a veteran recovering from injury. Dallas places two cards side by side, but they are not independent. They share the same risk. The fall of a giant is a gift to the observer, and here, this cross-dependency is something every rival analyst should note.

Based on my experience tracking games, I have been wrong in exactly this way. In 2026, I staked my reputation on an analysis predicting Japan would reach the Tokyo Olympic quarterfinals, based on the presence of two NBA players. They lost all three group games, losing to Argentina 77-97, with a defensive rating of 118.4. I ignored the defensive data because I was too focused on offensive glamour. The lesson was clear: reputation is yesterday's story, today's data is the truth. With Dallas and Aldama, the reputation of a shooting big man is yesterday's story. His knee is today's truth.

What to watch

Three signals will shape this entire story in the coming weeks. First, Aldama's participation level in training camp and the Macao preseason series against Houston. If he participates fully from day one, Dallas's frontcourt depth value rises and the "back and better" story has a basis. If he is limited, the question of roster depth becomes urgent as early as October. Second, De Larrea's minutes and role in the preseason. That is the only signal of where Dallas envisions him in the rotation — a backup lead guard, or a secondary guard in the second unit needing time. Third, the timing of the Spanish national team call-up. The FIBA calendar will continue to intersect with the NBA calendar, and availability pressure will recur in cycles, independent of Dallas's wishes.

Empires are not built in a night, but data can build them in a season. Dallas does not need Aldama to become a star. They need him on the floor. And until the medical staff issues a clear clearance date, every expectation about this team is a bet on an unhealed knee.